Response to: "A combination of complement activation products with autoantibodies predicts transition of probable lupus to systemic lupus erythematosus": comment on the article by Lambers et al Reply

Wietske M Lambers*, Johanna Westra, Hendrika Bootsma, Karina de Leeuw

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

We thank Dr Alexander and Dr Weinstein for their response to our review.1 We welcome the attempt to develop a diagnostic test that can predict progression to systemic lupus erythematosus (SLE). Early identification of SLE is one of the main challenges faced by clinicians, and is hindered by both the heterogeneous presenting symptoms of the disease, as well as overlap with other diseases.2,3 Timely treatment, however, is important in order to limit disease progression, and prevent organ damage and mortality.4.

Original languageEnglish
Pages (from-to)1827-1828
Number of pages4
JournalARTHRITIS CARE & RESEARCH
Volume72
Issue number12
Early online date25-Sep-2020
DOIs
Publication statusPublished - Dec-2020

Cite this